Xilio Therapeutics, Inc.
USD9.27
+0.22 (+2.43%)
CEO
Rene Russo
IPO Date
2021-10-22
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.02
Prev. Close
$9.05
Day Low
$8.88
Day High
$9.54
52W Low
$6.47
52W High
$12.74
Market Cap
$0.06B
Volume
0.16M
| 5,000 |
| $7.99 |
| 12 Jun 2026 | Curran Daniel J. | director | A-Award | Acquired | 5,000 | $7.99 |
| 12 Jun 2026 | Xu Yuan | director | A-Award | Acquired | 5,000 | $7.99 |
| 12 Jun 2026 | ROSS ROBERT W. | director | A-Award | Acquired | 5,000 | $7.99 |
| 12 Jun 2026 | Bonstein Sara | director | A-Award | Acquired | 5,000 | $7.99 |
| 12 Jun 2026 | Brennan Aoife | director | A-Award | Acquired | 5,000 | $7.99 |
| 16 Apr 2026 | Blanchard Cheryl R | director | A-Award | Acquired | 10,000 | $8.40 |
| 16 Apr 2026 | Blanchard Cheryl R | — | Disposed | 0 | $0.00 |
| 30 Mar 2026 | Shannon James Samuel | director | P-Purchase | Acquired | 5,000 | $8.79 |